Better Therapeutics
San Francisco, US · Founded 2020 · Delaware corporation
Find your way into Better Therapeutics
244 people in our graph share verified history with the Better Therapeutics team — schools, employers, funds. One of them is your warm intro.
Lyle McCullochunlockedknows Mark Heinen · together at Coopers & Lybrand (overlapped)
×10knows the team · via Coopers & Lybrand
knows the team · via University of Oklahoma - Price College of Business
Founders & leadership
Better Therapeutics was founded in 2020 by Kristin Wynholds.
KW
Kristin WynholdsFounder
FK
Frank KarbeExecutive
MH
Mark HeineninChief Financial Officer2021–2023Mark Heinen has served as CFO at multiple technology, SaaS, digital health, and aviation companies, with 30+ years of finance leadership experience including capital markets transactions, public company transformations, and M&A. His expertise includes deSPAC transactions, reverse mergers, venture debt structuring, and SOX compliance frameworks.
AA
Andrew ArmaninoNamed on SEC filing
GP
Geoffrey ParkerNamed on SEC filing
MB
Mark BermanNamed on SEC filing
DP
David PerryNamed on SEC filing
Board
RC
Richard CarmonaBoard director
RL
Risa Lavizzo-MoureyBoard director
EG
Elder GrangerBoard director
Reported raises · per SEC filings
Form D private placements$8.9M disclosed across 3 rounds · 2023–2024
▶$250KraisedJan 2024 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJan 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elder GrangerDirector
- Richard CarmonaDirector
- Risa Lavizzo-MoureyDirector
- David PerryExecutive Officer, Director
- Kristin WynholdsExecutive Officer
- Geoffrey ParkerDirector
- Frank KarbeExecutive Officer, Director
- Andrew ArmaninoDirector
- Mark BermanExecutive Officer
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.1MraisedAug 2023 · 10 investors · BiotechnologyRule 506(b)
▶$2.1MraisedAug 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elder GrangerDirector
- Frank KarbeExecutive Officer, Director
- David PerryExecutive Officer, Director
- Kristin WynholdsExecutive Officer
- Risa Lavizzo-MoureyDirector
- Geoffrey ParkerDirector
- Mark HeinenExecutive Officer
- Mark BermanExecutive Officer
- Andrew ArmaninoDirector
- Richard CarmonaDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Sales commissions
- $126.9K
- Placement agents
- Titan Partners Group LLC, a division of American Capital Partners, LLC, Chardan Capital Markets LLC
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$6.5MraisedApr 2023 · 9 investors · BiotechnologyRule 506(b)
▶$6.5MraisedApr 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank KarbeExecutive Officer, Director
- Andrew ArmaninoDirector
- Geoffrey ParkerDirector
- Richard CarmonaDirector
- Mark HeinenExecutive Officer
- Mark BermanExecutive Officer
- Risa Lavizzo-MoureyDirector
- Elder GrangerDirector
- David PerryExecutive Officer, Director
- Kristin WynholdsExecutive Officer
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- Sales commissions
- $325K
- Placement agents
- Chardan Capital Markets LLC, Brookline Capital Markets, a division of Arcadia Securities, LLC
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Better Therapeutics?
- Better Therapeutics was founded by Kristin Wynholds in 2020.
- How much funding has Better Therapeutics raised?
- Better Therapeutics has disclosed $8.9M raised across 3 rounds.
- Where is Better Therapeutics headquartered?
- Better Therapeutics is headquartered in San Francisco, US.